Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:antineoplastic_agent gptkb:anthracene_derivative |
| gptkbp:ATCCode |
L01DB07
|
| gptkbp:CASNumber |
87109-27-1
|
| gptkbp:category |
gptkb:anthracenedione
antitumor agent |
| gptkbp:chemicalFormula |
C22H20N4O2
|
| gptkbp:hasInChIKey |
QJQYQKZDHXHZMJ-UHFFFAOYSA-N
|
| gptkbp:hasSMILES |
C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C=CC(=C3)N(C)C4=CC=CC=C4N(C)C
|
| gptkbp:mechanismOfAction |
DNA intercalation
topoisomerase II inhibition |
| gptkbp:molecularWeight |
372.42 g/mol
|
| gptkbp:PubChem_CID |
24199
CHEMBL2105932 |
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:synonym |
Bisantrene dihydrochloride
Bisantrene hydrochloride |
| gptkbp:UNII |
6QX8J8A4QF
|
| gptkbp:usedFor |
gptkb:acute_myeloid_leukemia
|
| gptkbp:bfsParent |
gptkb:SD7932
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Bisantrene
|